Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer
Emma G Khoury, Sarah J Nevitt, William Rohde Madsen, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210880-e2210880
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 127
Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021
Weiqiu Jin, Kaichen Huang, Zeyu Ding, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Clinical course and management of COVID-19 in the era of widespread population immunity
Eric A. Meyerowitz, Jake Scott, Aaron Richterman, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 2, pp. 75-88
Closed Access | Times Cited: 33
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Astha Thakkar, Kith Pradhan, Benjamin Duva, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 17
Mortalidad por Coronavirus (COVID) SARS-CoV-2 en pacientes oncológicos
Julián Andrés Hoyos-Pulgarín, Omar Armando Gutiérrez Durán, Sara Camila Castiblanco-Arroyave, et al.
IATREIA (2025) Vol. 38, Iss. 3
Open Access
Association between COVID-19 history and postoperative delirium in elderly patient undergoing elective surgery: a prospective, two-center observational cohort study
Wen Duan, Jin-Jin Yang, Pan-Pan Fang, et al.
Anesthesiology and Perioperative Science (2025) Vol. 3, Iss. 1
Open Access
When to resume antitumor therapy in COVID-19-infected tumor patients: a retrospective, real-world study
Xiaofen Pan, Mengyuan Zhu, Gan Huang, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 4
Open Access
COVID-19 and Lung Cancer Survival: An Updated Systematic Review and Meta-Analysis
Simone Oldani, Fausto Petrelli, Giuseppina Dognini, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5706-5706
Open Access | Times Cited: 26
Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study
Lance Turtle, Sarah Elliot, Thomas M Drake, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 5, pp. 636-648
Open Access | Times Cited: 4
Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19
Jheng‐Yan Wu, Mei‐Yuan Liu, Ting-Hui Liu, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 6, pp. 106984-106984
Closed Access | Times Cited: 11
Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
Kelly S. Chien, Christine B. Peterson, Elliana Young, et al.
Blood Advances (2023) Vol. 7, Iss. 19, pp. 5691-5697
Open Access | Times Cited: 10
Is COVID-19 severity associated with telomere length? A systematic review and meta-analysis
Madhumitha Haridoss, Lavanya Ayyasamy, Bhavani Shankara Bagepally
Virus Genes (2023) Vol. 59, Iss. 4, pp. 489-498
Open Access | Times Cited: 10
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
Massimo Franchini, Arturo Casadevall, Michael J. Joyner, et al.
Life (2023) Vol. 13, Iss. 1, pp. 134-134
Open Access | Times Cited: 9
Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC
Wenyu Wu, Xin Jiao, Wen-xin Song, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Hospital and post-discharge mortality in COVID-19 patients with a preexisting cancer diagnosis in Iran
Monireh Sadat Seyyedsalehi, Marveh Rahmati, Reza Ghalehtaki, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review
Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, et al.
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 159-187
Open Access | Times Cited: 7
“I Have Constant Fear”: A National Qualitative Study on the Impact of COVID-19 on Cancer Care and Potential Solutions to Improve the Cancer Care Experience During the COVID-19 Pandemic
Gladys M. Rodriguez, Dhanya Kumar, Manali I. Patel
JCO Oncology Practice (2023) Vol. 19, Iss. 7, pp. 427-434
Closed Access | Times Cited: 6
Risk factors for mortality among lung cancer patients with covid-19 infection: A systematic review and meta-analysis
Mingyue Wu, Siru Liu, Changyu Wang, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291178-e0291178
Open Access | Times Cited: 6
Risk of COVID‐19 death for people with a pre‐existing cancer diagnosis prior to COVID‐19‐vaccination: A systematic review and meta‐analysis
Julia Steinberg, Suzanne Hughes, Harriet Hui, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 8, pp. 1394-1412
Open Access | Times Cited: 6
COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
The Complex Interplay between Serum Testosterone and the Clinical Course of Coronavirus Disease 19 Pandemic: A Systematic Review of Clinical and Preclinical Evidence
Riccardo Leni, Federico Belladelli, Sara Baldini, et al.
The World Journal of Men s Health (2023) Vol. 41, Iss. 3, pp. 466-466
Open Access | Times Cited: 5
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far
Hubert Schrezenmeier, Simone Hoffmann, Henrike Hofmann, et al.
Hämostaseologie (2023) Vol. 43, Iss. 01, pp. 067-074
Open Access | Times Cited: 5
The case for counting multiple causes of death in the COVID-19 era
Marie-Pier Petit, Nadine Ouellette, Robert Bourbeau
International Journal of Epidemiology (2023) Vol. 53, Iss. 1
Closed Access | Times Cited: 5
SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care
Lindsey Wang, William Wang, Rong Xu, et al.
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101384-101384
Open Access | Times Cited: 9
Response to COVID‐19 vaccination in patients on cancer therapy: Analysis in a SARS‐CoV‐2‐naïve population
George Cavic, Andrew A. Almonte, Sarah M. Hicks, et al.
Asia-Pacific Journal of Clinical Oncology (2024) Vol. 20, Iss. 3, pp. 379-385
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top